Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A Danish cohort study

Cancer Causes and Control

Volumn 20, Issue 5, 2009, Pages 731-740

  Friis, Søren ^a   Poulsen, Aslak H ^a   Sørensen, Henrik Toft ^b   Tjønneland, Anne ^a   Overvad, Kim ^b   Vogel, Ulla ^c,d   McLaughlin, Joseph K ^e,f   Blot, William J ^e,f   Olsen, Jørgen H ^a  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d ROSKILDE UNIVERSITY   (Denmark)

^e INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^f VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Cohort study; Colorectal neoplasms; Epidemiology; Non steroidal anti inflammatory agents; Risk

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DENMARK; DOSE RESPONSE; DRUG USE; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RISK REDUCTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COHORT STUDIES; COLORECTAL NEOPLASMS; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 67349144669     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-008-9286-7     Document Type: Article

References (56)

1. CM Ulrich J Bigler JD Potter 2006 Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics Nat Rev Cancer 6 130 140 10.1038/nrc1801
2. C Dube A Rostom G Lewin 2007 The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force Ann Intern Med 146 365 375
3. A Rostom C Dube G Lewin 2007 Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force Ann Intern Med 146 376 389
4. U.S. Preventive Services Task Force 2007 Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 146 361 364
5. JA Baron BF Cole RS Sandler 2003 A randomized trial of aspirin to prevent colorectal adenomas N Engl J Med 348 891 899 10.1056/NEJMoa021735
6. RS Sandler S Halabi JA Baron 2003 A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer N Engl J Med 348 883 890 10.1056/NEJMoa021633
7. R Benamouzig J Deyra A Martin 2003 Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial Gastroenterology 125 328 336 10.1016/S0016-5085(03)00887-4
8. RF Logan MJ Grainge VC Shepherd NC Armitage KR Muir 2008 Aspirin and folic acid for the prevention of recurrent colorectal adenomas Gastroenterology 134 29 38 10.1053/j.gastro.2007.10.014
9. FM Giardiello SR Hamilton AJ Krush 1993 Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis N Engl J Med 328 1313 1316 10.1056/NEJM199305063281805
10. N Arber CJ Eagle J Spicak 2006 Celecoxib for the prevention of colorectal adenomatous polyps N Engl J Med 355 885 895 10.1056/NEJMoa061652
11. MM Bertagnolli CJ Eagle AG Zauber 2006 Celecoxib for the prevention of sporadic colorectal adenomas N Engl J Med 355 873 884 10.1056/NEJMoa061355
12. JA Baron RS Sandler RS Bresalier 2006 A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas Gastroenterology 131 1674 1682 10.1053/j.gastro.2006.08.079
13. PH Gann JE Manson RJ Glynn JE Buring CH Hennekens 1993 Low-dose aspirin and incidence of colorectal tumors in a randomized trial J Natl Cancer Inst 85 1220 1224 10.1093/jnci/85.15.1220 (Pubitemid 23223527)
14. NR Cook IM Lee JM Gaziano 2005 Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial JAMA 294 47 55 10.1001/jama.294.1.47
15. E Flossmann PM Rothwell 2007 Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies Lancet 369 1603 1613 10.1016/S0140-6736(07)60747-8
16. MJ Thun MM Namboodiri EE Calle WD Flanders CW Heath Jr 1993 Aspirin use and risk of fatal cancer Cancer Res 53 1322 1327 (Pubitemid 23097110)
17. JP Collet C Sharpe E Belzile JF Boivin J Hanley L Abenhaim 1999 Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing Br J Cancer 81 62 68 10.1038/sj.bjc.6690651
18. AT Chan EL Giovannucci JA Meyerhardt ES Schernhammer GC Curhan CS Fuchs 2005 Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer JAMA 294 914 923 10.1001/jama.294.8.914
19. M Allison C Garland R Chlebowski 2006 The association between aspirin use and the incidence of colorectal cancer in women Am J Epidemiol 164 567 575 10.1093/aje/kwj250
20. SC Larsson E Giovannucci A Wolk 2006 Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden Br J Cancer 95 1277 1279 10.1038/sj.bjc.6603442
21. EJ Jacobs MJ Thun EB Bain C Rodriguez SJ Henley EE Calle 2007 A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence J Natl Cancer Inst 99 608 615 10.1093/jnci/djk132
22. AT Chan EL Giovannucci JA Meyerhardt ES Schernhammer K Wu CS Fuchs 2008 Aspirin dose and duration of use and risk of colorectal cancer in men Gastroenterology 134 21 28 10.1053/j.gastro.2007.09.035
23. L Rosenberg JR Palmer AG Zauber ME Warshauer PD Stolley S Shapiro 1991 A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer J Natl Cancer Inst 83 355 358 10.1093/jnci/83.5.355
24. W Smalley WA Ray J Daugherty MR Griffin 1999 Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study Arch Intern Med 159 161 166 10.1001/archinte.159.2.161
25. LA Garcia-Rodriguez C Huerta-Alvarez 2001 Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs Epidemiology 12 88 93 10.1097/00001648-200101000-00015
26. LB Sansbury RC Millikan JC Schroeder PG Moorman KE North RS Sandler 2005 Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites Am J Epidemiol 162 548 558 10.1093/aje/kwi248
27. S Kim JA Baron LA Mott 2006 Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States) Cancer Causes Control 17 1299 1304 10.1007/s10552-006-0075-x
28. B Agarwal CV Rao S Bhendwal 1999 Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac Gastroenterology 117 838 847 10.1016/S0016-5085(99)70342-2
29. BS Reddy CX Wang AN Kong 2006 Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats Cancer Res 66 4542 4546 10.1158/0008-5472.CAN-05-4428
30. M Hoffmeister J Chang-Claude H Brenner 2007 Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a population-based case-control study Int J Cancer 121 1325 1330 10.1002/ijc.22796
31. H Xiao CS Yang 2008 Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention Int J Cancer 123 983 990 10.1002/ijc.23718
32. S Bonovas K Filioussi CS Flordellis NM Sitaras 2007 Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients J Clin Oncol 25 3462 3468 10.1200/JCO.2007.10.8936
33. ET Hawk B Levin 2005 Colorectal cancer prevention J Clin Oncol 23 378 391 10.1200/JCO.2005.08.097
34. AW DuPont MR Arguedas CM Wilcox 2007 Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis Aliment Pharmacol Ther 26 431 441 (Pubitemid 47063144)
35. A Tjønneland A Olsen K Boll 2007 Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark Scand J Public Health 35 432 441 10.1080/14034940601047986
36. TF Andersen M Madsen J Jørgensen L Mellemkjær JH Olsen 1999 The Danish National Hospital Register. A valuable source of data for modern health sciences Dan Med Bull 46 263 268 (Pubitemid 29299976)
37. D Gaist HT Sørensen J Hallas 1997 The Danish prescription registries Dan Med Bull 44 445 448 (Pubitemid 27382061)
38. L Frank 2000 Epidemiology. When an entire country is a cohort Science 287 2398 2399 10.1126/science.287.5462.2398
39. World Health Organization Collaborating Centre for Drug Statistics Methodology (2001) Guidelines for ATC classification and DDD assignments. World Health Organization Collaborating Centre for Drug Statistics Methodology, Oslo
40. HT Sørensen S Friis B Nørgård 2003 Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study Br J Cancer 88 1687 1692 10.1038/sj.bjc.6600945
41. Danish Board of Health (1995) Danish Classification of Surgical Procedures and Therapies. Danish Board of Health, Copenhagen
42. HH Storm EV Michelsen IH Clemmensen J Pihl 1997 The Danish Cancer Registry-history, content, quality and use Dan Med Bull 44 535 539
43. M Vyberg B Bjerregaard M Bak I Gram H Hvolris 2005 Pathology database. Danish Society of Pathologic Anatomy and Cytology Ugeskr Laeger 167 1401
44. National Board of Health (2006) Cancer incidence in Denmark, 2001. National Board of Health, Copenhagen, Denmark
45. Engholm G, Storm HH, Ferlay J et al. (2008) NORDCAN: cancer incidence, mortality and prevalence in the Nordic Countries. Association of Nordic Cancer Registries. Danish Cancer Society, Copenhagen
46. World Health Organization (2000) Obesity: preventing and managing the global epidemic. WHO Technical Report Series No 894. World Health Organization, Geneva
47. Danish Medicines Agency (2008) Medicinal Product Statistics in Denmark 2003-2007. Danish Medicines Agency, Copenhagen
48. Y Vinogradova J Hippisley-Cox C Coupland RF Logan 2007 Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study Gastroenterology 133 393 402 10.1053/j.gastro.2007.05.023
49. S Friis HT Sørensen JK McLaughlin SP Johnsen WJ Blot JH Olsen 2003 A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin Br J Cancer 88 684 688 10.1038/sj.bjc.6600760
50. World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington DC
51. T Pischon U Nothlings H Boeing 2008 Obesity and cancer Proc Nutr Soc 67 128 145 10.1017/S0029665108006976
52. MJ Gunter MF Leitzmann 2006 Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes J Nutr Biochem 17 145 156 10.1016/j.jnutbio.2005. 06.011
53. RA Gupta RN DuBois 2001 Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 Nat Rev Cancer 1 11 21 (Pubitemid 33741877)
54. K Subbaramaiah AJ Dannenberg 2003 Cyclooxygenase 2: a molecular target for cancer prevention and treatment Trends Pharmacol Sci 24 96 102 10.1016/S0165-6147(02)00043-3
55. ML Slattery W Samowitz M Hoffman KN Ma TR Levin S Neuhausen 2004 Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway Cancer Epidemiol Biomarkers Prev 13 538 545 (Pubitemid 38737888)
56. JH Olsen S Friis AH Poulsen 2008 Use of NSAIDs, smoking and lung cancer risk Br J Cancer 98 232 237 10.1038/sj.bjc.6604151